Delivery Order SPE2DB20D3103-SPE2DB25FQ3N3
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,906.45 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injection on October 23, 2025, with an ultimate completion date of October 24, 2025. This non-competitive, firm fixed-price delivery order represents a single shipment of the GLP-1 receptor agonist medication used for weight management. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management. This firm fixed price delivery order, valued at $1,041.62, represents a non-competitive set-aside award under DLA's pharmaceutical supply chain. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $1,525.20 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price, competitively awarded delivery order was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,213.05 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. The contract was awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, and utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.96 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen (0.5ml), a GLP-1 receptor agonist medication used for weight management. The contract is a firm fixed-price delivery order with no set-aside designation, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,906.47 for Zepbound 2.5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $12,879.01 for Zepbound 5 mg/0.5 mL pen injectors, a GLP-1 receptor agonist medication used for weight management. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract utilizes no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a $7,218.52 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections (0.5 ml), a GLP-1 receptor agonist medication used for weight management. The contract, executed on August 26, 2025, with completion targeted for August 27, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,050.40 and an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,795.11 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on November 26, 2025, with completion scheduled for November 28, 2025. The award was issued as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from...